Generics
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
19 January 2026 - Healthcare technology company Apiject Holdings Inc announced on Friday that it has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Caroli...
Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma
16 January 2026 - Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA, BSE:524715), an India-based specialty generic drug company, announced on Thursday that UNLOXCYT (cosibelimab-ipdl) is now availa...
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated...
ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic
5 January 2026 - Taiwanese pharmaceutical company ScinoPharm Taiwan (TWSE: 1789) said on Monday that it has received US Food and Drug Administration approval for its Glatiramer Acetate Injection for t...
ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA
5 January 2026 - ScinoPharm Taiwan Ltd (TWSE:1789), a process R&D and API manufacturing service provider to the global pharmaceutical industry, announced on Monday that it has received approval fr...
International Isotopes Inc to change name to Radnostix Inc
2 January 2026 - International Isotopes Inc (INIS) (OTCQB:INIS), a US supplier of generic sodium iodide I-131 radio-pharmaceutical drug products for hyperthyroidism and thyroid cancer, announced on We...